United States - English - NLM (National Library of Medicine)

onpoint, inc - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - pyrithione zinc 10 mg in 1 ml - anti-dandruff helps prevent recurrence of flaking and itching associated with dandruff condition worsens or does not improve after regular use as directed

United States - English - NLM (National Library of Medicine)

demoulas super markets, inc - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - pyrithione zinc 1 g in 100 ml - anti-dandruff helps prevent recurrence of flaking and itching associated with dandruff - condition worsens or does not improve after regular use as directed

United States - English - NLM (National Library of Medicine)

demoulas super markets, inc - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - pyrithione zinc 10 mg in 1 ml - anti-dandruff helps prevent recurrence of flaking and itching associated with dandruff - condition worsens or does not improve after regular use as directed

United States - English - NLM (National Library of Medicine)

demoulas super markets, inc - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - pyrithione zinc 1 g in 100 ml - anti-dandruff helps prevent recurrence of flaking and itching associated with dandruff condtion worsens or does not improve after regular use as directed

United States - English - NLM (National Library of Medicine)

meijer distribution, inc - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - pyrithione zinc 10 mg in 1 ml - anti-dandruff helps prevent recurrence of flaking and itching associated with dandruff condition worsens or does not improve after regular use as directed

United States - English - NLM (National Library of Medicine)

publix super markets, inc - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - pyrithione zinc 10 mg in 1 ml - anti-dandruff helps prevent recurrence of flaking and itching associated with dandruff - condition worsens or does not improve after regular use as directed

United States - English - NLM (National Library of Medicine)

meijer distribution, inc - zinc oxide 40% - skin protectant - helps treat and prevent diaper rash - protects chafed skin due to diaper rash and helps seal out wetness - condition worsens - symptoms last more than 7 days or clear up and occur again within a few days

United States - English - NLM (National Library of Medicine)

vi-jon, llc - diphenhydramine hcl 2%, zinc acetate 0.1% - external analgesic skin protectant - for the temporary relief of pain and itching associated with ■ insect bites ■ minor skin irritations ■ sunburn ■ minor burns ■ minor cuts ■ scrapes ■ rashes due to poison: ■ ivy ■ oak ■ sumac - dries the oozing and weeping of poison: ■ ivy ■ oak ■ sumac - on large areas of the body - with any other product containing diphenhydramine, even one taken by mouth ■ on chicken pox ■ on measles ■ condition worsens ■ symptoms last more than 7 days or clear up and occur again within a few days

United States - English - NLM (National Library of Medicine)

vi-jon - menthol 0.15%, zinc oxide 1.0% - external analgesic skin protectant uses for the temporary relief of paina and itching due to: - monor cuts - sunburn - insect bites - poison ivy - poison oak - poison sumac - scrapes - minor burns - minor skin irritations dries the oozing and weeping of: - poison ivy - poison oak - poison sumac condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days

United States - English - NLM (National Library of Medicine)

a-s medication solutions - salmonella typhi ty2 vi polysaccharide antigen (unii: 7194h8w3kt) (salmonella typhi ty2 vi polysaccharide antigen - unii:7194h8w3kt) - salmonella typhi ty2 vi polysaccharide antigen 25 ug in 0.5 ml - typhim vi vaccine is indicated for active immunization for the prevention of typhoid fever caused by s typhi and is approved for use in persons two years of age or older. immunization with typhim vi vaccine should occur at least two weeks prior to expected exposure to s typhi . typhim vi vaccine is not indicated for routine immunization of individuals in the united states (us). (14) selective immunization against typhoid fever is recommended under the following circumstances: 1) travelers to areas where a recognized risk of exposure to typhoid exists, particularly ones who will have prolonged exposure to potentially contaminated food and water, 2) persons with intimate exposure (ie, continued household contact) to a documented typhoid carrier, and 3) workers in microbiology laboratories who frequently work with s typhi . (14) typhoid vaccination is not required for international travel, but is recommended for travelers to such areas as africa, asia, and central and south america where there is a recognized r